{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T08:03:43Z","timestamp":1762848223898,"version":"build-2065373602"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,11]]},"DOI":"10.7759\/cureus.96536","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T08:00:47Z","timestamp":1762848047000},"source":"Crossref","is-referenced-by-count":0,"title":["Complete Pancreatic Agenesis Presenting With Neonatal Diabetes and Exocrine Insufficiency: A Case Report"],"prefix":"10.7759","author":[{"given":"Faisal","family":"Alshareef","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah   H","family":"Alfares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalal","family":"Alshathri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1993.02160300013005","article-title":"Permanent neonatal diabetes mellitus and pancreatic exocrine insufficiency resulting from congenital pancreatic agenesis","volume":"147","author":"Wright NM","year":"1993","unstructured":"Wright NM, Metzger DL, Borowitz SM, Clarke WL. Permanent neonatal diabetes mellitus and pancreatic exocrine insufficiency resulting from congenital pancreatic agenesis. Am J Dis Child. 1993, 147:607-9. 10.1001\/archpedi.1993.02160300013005","journal-title":"Am J Dis Child"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12122","article-title":"Biallelic PDX1 (insulin promoter factor 1) mutations causing neonatal diabetes without exocrine pancreatic insufficiency","volume":"30","author":"De Franco E","year":"2013","unstructured":"De Franco E, Shaw-Smith C, Flanagan SE, et al.. Biallelic PDX1 (insulin promoter factor 1) mutations causing neonatal diabetes without exocrine pancreatic insufficiency. Diabet Med. 2013, 30:e197-200. 10.1111\/dme.12122","journal-title":"Diabet Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-0865","article-title":"The homeodomain-interacting protein kinase 2 regulates insulin promoter factor-1\/pancreatic duodenal homeobox-1 transcriptional activity","volume":"150","author":"Boucher MJ","year":"2009","unstructured":"Boucher MJ, Simoneau M, Edlund H. The homeodomain-interacting protein kinase 2 regulates insulin promoter factor-1\/pancreatic duodenal homeobox-1 transcriptional activity. Endocrinology. 2009, 150:87-97. 10.1210\/en.2007-0865","journal-title":"Endocrinology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/ng0197-106","article-title":"Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence","volume":"15","author":"Stoffers DA","year":"1997","unstructured":"Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet. 1997, 15:106-10. 10.1038\/ng0197-106","journal-title":"Nat Genet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/ng.1035","article-title":"GATA6 haploinsufficiency causes pancreatic agenesis in humans","volume":"44","author":"Allen HL","year":"2011","unstructured":"Allen HL, Flanagan SE, Shaw-Smith C, et al.. GATA6 haploinsufficiency causes pancreatic agenesis in humans. Nat Genet. 2011, 44:20-2. 10.1038\/ng.1035","journal-title":"Nat Genet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2019.03.018","article-title":"A specific CNOT1 mutation results in a novel syndrome of pancreatic agenesis and holoprosencephaly through impaired pancreatic and neurological development","volume":"104","author":"De Franco E","year":"2019","unstructured":"De Franco E, Watson RA, Weninger WJ, et al.. A specific CNOT1 mutation results in a novel syndrome of pancreatic agenesis and holoprosencephaly through impaired pancreatic and neurological development. Am J Hum Genet. 2019, 104:985-9. 10.1016\/j.ajhg.2019.03.018","journal-title":"Am J Hum Genet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-010-9150-4","article-title":"6q24 transient neonatal diabetes","volume":"11","author":"Temple IK","year":"2010","unstructured":"Temple IK, Shield JP. 6q24 transient neonatal diabetes. Rev Endocr Metab Disord. 2010, 11:199-204. 10.1007\/s11154-010-9150-4","journal-title":"Rev Endocr Metab Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1356","article-title":"Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A","volume":"97","author":"Stanescu DE","year":"2012","unstructured":"Stanescu DE, Hughes N, Kaplan B, Stanley CA, De Le\u00f3n DD. Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A. J Clin Endocrinol Metab. 2012, 97:E2026-30. 10.1210\/jc.2012-1356","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-023-01565-x","article-title":"Primate-specific ZNF808 is essential for pancreatic development in humans","volume":"55","author":"De Franco E","year":"2023","unstructured":"De Franco E, Owens ND, Montaser H, et al.. Primate-specific ZNF808 is essential for pancreatic development in humans. Nat Genet. 2023, 55:2075-81. 10.1038\/s41588-023-01565-x","journal-title":"Nat Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12111","article-title":"A novel mutation in GATA6 causes pancreatic agenesis","volume":"16","author":"Stanescu DE","year":"2015","unstructured":"Stanescu DE, Hughes N, Patel P, De Le\u00f3n DD. A novel mutation in GATA6 causes pancreatic agenesis. Pediatr Diabetes. 2015, 16:67-70. 10.1111\/pedi.12111","journal-title":"Pediatr Diabetes"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030046","article-title":"Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1","volume":"88","author":"Schwitzgebel VM","year":"2003","unstructured":"Schwitzgebel VM, Mamin A, Brun T, et al.. Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1. J Clin Endocrinol Metab. 2003, 88:4398-406. 10.1210\/jc.2003-030046","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000354219","article-title":"Diabetes mellitus in neonates and infants: genetic heterogeneity, clinical approach to diagnosis, and therapeutic options","volume":"80","author":"Rubio-Cabezas O","year":"2013","unstructured":"Rubio-Cabezas O, Ellard S. Diabetes mellitus in neonates and infants: genetic heterogeneity, clinical approach to diagnosis, and therapeutic options. Horm Res Paediatr. 2013, 80:137-46. 10.1159\/000354219","journal-title":"Horm Res Paediatr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12772","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: the diagnosis and management of monogenic diabetes in children and adolescents","volume":"19","author":"Hattersley AT","year":"2018","unstructured":"Hattersley AT, Greeley SA, Polak M, et al.. ISPAD Clinical Practice Consensus Guidelines 2018: the diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2018, 19:47-63. 10.1111\/pedi.12772","journal-title":"Pediatr Diabetes"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061759","article-title":"Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations","volume":"355","author":"Pearson ER","year":"2006","unstructured":"Pearson ER, Flechtner I, Nj\u00f8lstad PR, et al.. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med. 2006, 355:467-77. 10.1056\/NEJMoa061759","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70303-5","article-title":"Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1\/2 trial","volume":"14","author":"Pressler RM","year":"2015","unstructured":"Pressler RM, Boylan GB, Marlow N, et al.. Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1\/2 trial. Lancet Neurol. 2015, 14:469-77. 10.1016\/S1474-4422(14)70303-5","journal-title":"Lancet Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13057","article-title":"Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics","volume":"56","author":"Wilmshurst JM","year":"2015","unstructured":"Wilmshurst JM, Gaillard WD, Vinayan KP, et al.. Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics. Epilepsia. 2015, 56:1185-97. 10.1111\/epi.13057","journal-title":"Epilepsia"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-019-0449-1","article-title":"Agenesis of the dorsal pancreas presenting with diabetic ketoacidosis - a case report and literature review","volume":"19","author":"Yang T","year":"2019","unstructured":"Yang T, Yang X, Wang L, Mo J. Agenesis of the dorsal pancreas presenting with diabetic ketoacidosis - a case report and literature review. BMC Endocr Disord. 2019, 19:120. 10.1186\/s12902-019-0449-1","journal-title":"BMC Endocr Disord"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0127-7","article-title":"Bronchopulmonary dysplasia","volume":"5","author":"Th\u00e9baud B","year":"2019","unstructured":"Th\u00e9baud B, Goss KN, Laughon M, et al.. Bronchopulmonary dysplasia. Nat Rev Dis Primers. 2019, 5:78. 10.1038\/s41572-019-0127-7","journal-title":"Nat Rev Dis Primers"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2012.05.001","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis","volume":"11","author":"Ooi CY","year":"2012","unstructured":"Ooi CY, Durie PR. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis. J Cyst Fibros. 2012, 11:355-62. 10.1016\/j.jcf.2012.05.001","journal-title":"J Cyst Fibros"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2147\/CEG.S17634","article-title":"Enzyme replacement therapy for pancreatic insufficiency: present and future","volume":"4","author":"Fieker A","year":"2011","unstructured":"Fieker A, Philpott J, Armand M. Enzyme replacement therapy for pancreatic insufficiency: present and future. Clin Exp Gastroenterol. 2011, 4:55-73. 10.2147\/CEG.S17634","journal-title":"Clin Exp Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60098-8","article-title":"The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study","volume":"386","author":"De Franco E","year":"2015","unstructured":"De Franco E, Flanagan SE, Houghton JA, et al.. The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study. Lancet. 2015, 386:957-63. 10.1016\/S0140-6736(15)60098-8","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2009.00526.x","article-title":"Neonatal diabetes mellitus with pancreatic agenesis in an infant with homozygous IPF-1 Pro63fsX60 mutation","volume":"10","author":"Thomas IH","year":"2009","unstructured":"Thomas IH, Saini NK, Adhikari A, et al.. Neonatal diabetes mellitus with pancreatic agenesis in an infant with homozygous IPF-1 Pro63fsX60 mutation. Pediatr Diabetes. 2009, 10:492-6. 10.1111\/j.1399-5448.2009.00526.x","journal-title":"Pediatr Diabetes"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/416727-complete-pancreatic-agenesis-presenting-with-neonatal-diabetes-and-exocrine-insufficiency-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T08:00:48Z","timestamp":1762848048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/416727-complete-pancreatic-agenesis-presenting-with-neonatal-diabetes-and-exocrine-insufficiency-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.96536","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,11]]}}}